Back to search

University of Ioannina

Αντιφλεγμονώδεις, αντιαιμοπεταλιακές και αντικαρκινικές δράσεις συμπλόκων του κασσιτέρου με οργανικούς υποκαταστάτες σε in vitro, ex vivo και in vivo χημικά και βιολογικά μοντέλα

Abstract

dc:description

The newly synthesized complexes of Sn withthioamides, (C6H5)3Sn(BZO5), (C6H5)3Sn (BZT5), (CH3)2Sn(CBZT 2), (C4H9)2Sn(CBZT3), (C6H5)2Sn(CBZT4) & (C6H5)3Sn(CBZT5),were studied for their anticancer and antiplatelet- antimetastatic effects. Their cytotoxic effects were studied on a leiomyosarcoma cell line (LMS), isolated from tumors of Wistar rats induced by benzo(a)pyrene, on a human breast cancer cell line (MCF7), and on a healthy human fibroblast line(MRC5).The cytotoxicity of the ligand[5-chloro-2-mercaptobenzo-thiazol (CBZT)] of the CBZT3 and CBZT5, on LMS , was also studied. Cytotoxicity of the complexes on LMS, MCF7 and MRC5 was estimated by Trypan Blue staining and by the MTT method and colony forming ability of cells, whereas necrosis and apoptosis induced by the complexes on LMS, by the flow cytometry. The anti-aggregating effects of the complexes on human platelets- induced by ADP , PAF and LMS- were also estimated. The toxicity of the CBZT5 was estimated in 15 Wistar rats, by intraperitoneal infusion of 0,8mg, 8mg and 80mg /kg B.W. of the substance. The anticancer effects of the CBZT5 complex, was studied in 40 female Wistar rats with sarcomas induced by inoculation of 1,5 to 2,0 x106 LMS. The animals were separated in three groups: The Control Group (CG-10 animals).The Experimental-1 Group (EG-1) and the Experimental-2 Group (EG-2), of 15 animals each. In EG-1 & EG-2, CBZT5 was i.p administered at a total dose of 8 mg/kg B.W., divided in 4 doses, each every 5 days, in EG-1, and in 3 doses each every 10 days, in EG-2. In the animal groups, the survival time, the tumor growth rate, and the number of animals bearing metastases were studied, and tumor histology was performed. From cellular studies were found the following: · The more potent were CBZT3 and CBZT5, possessing an IC50: 0,264μM and 0,140μΜ respectively, exerting no cytotoxicity on MRC5 at IC50 concentrations. · The ligand CBZT manifested a sligh cytotoxicity on LMS (IC50 87.5μΜ) · Flow cytometry of LMS revealed that CBZT3 induced 13% necrosis and 85% apoptosis and CBZT5, 18% necrosis and 60% apoptosis. · CBZT3 and CBZT5 exerted a significant inhibition of human platelet aggregation indu-ced by LMS (IC50 CBZT3 :0,00537mM ,IC50 CBZT5 :0,0898mM). · Rats treated with CBZT5 manifested a significant prolongation of survival, (p<0001) and absence (0%) of metastases compared to the control group (40% with metastases). In conclusion, the organic complexes of Sn with thioamides, possess potent cytotoxic and antimetastatic effects, and low toxicity introducing them as possible successors of organometallic compounds used nowdays in chemotherapy.

Degree

thesis:*
Grantor dc:publisher
University of Ioannina
Year dc:date
2010

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Metsios, Apostolos
  • Μέτσιος, Απόστολος

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/22284

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Metsios, Apostolos; Μέτσιος, Απόστολος. Αντιφλεγμονώδεις, αντιαιμοπεταλιακές και αντικαρκινικές δράσεις συμπλόκων του κασσιτέρου με οργανικούς υποκαταστάτες σε in vitro, ex vivo και in vivo χημικά και βιολογικά μοντέλα. University of Ioannina, 2010. http://hdl.handle.net/10442/hedi/22284